A Double-Blind Randomized Placebo-Controlled Withdrawal Trial Comparing Memantine and Antipsychotics for the Long-Term Treatment of Function and Neuropsychiatric Symptoms in People With Alzheimer's Disease (MAIN-AD)
- Submitting institution
-
University of Exeter
- Unit of assessment
- 2 - Public Health, Health Services and Primary Care
- Output identifier
- 4544
- Type
- D - Journal article
- DOI
-
10.1016/j.jamda.2014.11.002
- Title of journal
- Journal of the American Medical Directors Association
- Article number
- -
- First page
- 316
- Volume
- 16
- Issue
- 4
- ISSN
- 1525-8610
- Open access status
- Out of scope for open access requirements
- Month of publication
- December
- Year of publication
- 2014
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- Yes
- Number of additional authors
-
15
- Research group(s)
-
C - Health Service Research
- Citation count
- 17
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author, Creese, made a substantial contribution to the organisation of the conduct of the study, to carrying out the study and helped draft the output. Creese was the trial manager for the whole study.
- Non-English
- No
- English abstract
- -
